Multimmune GmbH
Records under this name other than the patents Multimmune GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 6 of 6 · Back to Multimmune GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,700,737 | Therapeutic and diagnostic anti-Hsp70 antibodies Term ended Term ended Jan 19, 2026 · From the USPTO record | Term ended | Term ended Jan 19, 2026 | From the USPTO record |
| US 8,440,188 | Therapeutic and diagnostic anti-HSP70 antibodies Term ended Term ended Dec 6, 2024 · From the USPTO record | Term ended | Term ended Dec 6, 2024 | From the USPTO record |
| US 7,517,948 | HSP70 Peptide Stimulating Natural Killer (NK) Cell Activity and Uses Thereof Term ended Term ended Nov 10, 2022 · High confidence | Term ended | Term ended Nov 10, 2022 | High confidence |
| US 7,745,399 | HSP70 Peptide Stimulating Natural Killer (NK) Cell Activity and Uses Thereof Lapsed on the fee record Ended Jun 29, 2018 · High confidence | Lapsed on the fee record | Ended Jun 29, 2018 | High confidence |
| US 7,722,863 | Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells Lapsed on the fee record Ended May 25, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 25, 2018 | From the USPTO record |
| US 7,943,740 | Compositions and methods for the treatment and diagnosis of neoplastic and infectious diseases Lapsed on the fee record Ended May 17, 2015 · From the USPTO record | Lapsed on the fee record | Ended May 17, 2015 | From the USPTO record |